The Drone Defense Supercycle: America’s New Airpower Revolution – Downloadable Thematic Report
Subscribe to our Weekly Newsletter to Receive All Research Contact: Executives-Edge.com Rayk@capmarketsmedia.com
Subscribe to our Weekly Newsletter to Receive All Research Contact: Executives-Edge.com Rayk@capmarketsmedia.com
By Karen Roman Vinson & Elkins made known the full list of its 10 lawyers chosen to become partners and 12 lawyers promoted to counsel, all designations effective Jan. 1, 2026. Lawyers Elected for Partnership: Zach Banks, Finance, Houston Jordan...
Download the Complete Report Here By Brandon Hornback Binah Capital Group, Inc. (NASDAQ: BCG) delivered a top-down beat, led by strong asset under management (AUM) growth, clearing the way for further expansion. The company posted an impressive 9.5% increase in...
Subscribe to our Weekly Newsletter to Receive All Research Contact: Executives-Edge.com Rayk@capmarketsmedia.com
Download the Complete Report Here By Brandon Hornback Donald Trump Jr.-backed GrabAGun Digital Holdings Inc. (NYSE: PEW) continues to build momentum amid a challenging industry backdrop. Revenue grew an impressive 10% to $22.3 million in the third quarter, sharply outperforming...
Subscribe to our Weekly Newsletter to Receive All Research Contact: Executives-Edge.com Rayk@capmarketsmedia.com
Tech Edge hosted a fireside chat on Nov. 17 from the Nasdaq Marketsite with Jared Muroff, Head of Special Situations at Octus. The in-person interview was joined by Editor-at-Large Jarrett Banks, and they discussed trends in stressed and distressed sectors as...
The platform that brought Gen Z together during the pandemic is making a strategic shift, and it’s built on a decade of safety innovation By Exec Edge Editorial Staff When Sacha Lazimi, Jérémie Aouate, and Arthur Patora founded Yubo in...
IPO Edge hosted a fireside chat with Knightscope, Inc. (Nasdaq: KSCP) on Nov. 13 to discuss the company’s launch of the K7 Autonomous Security Robot, the company’s rock-solid balance sheet, and what’s in store for 2026. The event featured William...
By Daniella Parra March Biosciences said that the FDA granted regenerative medicine advanced therapy its first-in-class CD5-targeted CAR-T cell therapy for relapsed or refractory CD5-positive T-cell lymphoma. The designation is based on encouraging early Phase 2 data showing clinical activity and...